Multiple Endocrine Neoplasia Type 2

Home
Articles

Multiple Endocrine Neoplasia Type 2

Pheochromocytoma |Blood pressure |Adrenal tumor administrator 3 Views • 2 years ago

This video gives the complete knowledge about Pheochromocytoma. Pheochromocytoma is a rare tumor that originates in the chromaffin cells of the adrenal gland, which are responsible for producing and secreting hormones such as adrenaline and noradrenaline. These hormones are important for regulating the body's response to stress and play a role in controlling blood pressure, heart rate, and metabolism. Pheochromocytoma can also occur outside of the adrenal gland, in other parts of the body such as the sympathetic ganglia.

The symptoms of pheochromocytoma can vary, but they often include episodes of high blood pressure, sweating, headaches, rapid heartbeat, and anxiety. These symptoms can occur spontaneously or may be triggered by stress, exercise, or certain medications. In some cases, pheochromocytoma can cause more severe symptoms, such as chest pain, stroke, or heart attack.

Pheochromocytoma is usually diagnosed through a combination of blood tests, imaging tests (such as CT or MRI scans), and a biopsy of the tumor. Genetic testing may also be recommended, as pheochromocytoma can be associated with inherited genetic mutations, such as those found in von Hippel-Lindau disease or multiple endocrine neoplasia type 2.

Treatment for pheochromocytoma typically involves surgical removal of the tumor, which can often be done through minimally invasive techniques. Medications such as alpha-blockers and beta-blockers may also be used to help control blood pressure and other symptoms before and after surgery. In some cases, radiation therapy or chemotherapy may be recommended if the tumor has spread to other parts of the body.

Because pheochromocytoma is a rare and complex condition, it is important to seek care from a specialized medical center with experience in managing this disease. With prompt and appropriate treatment, the prognosis for most people with pheochromocytoma is generally favorable.

#MRCP - PART ONE #Endocrinology 2 administrator 2 Views • 2 years ago

Endocrine Keys
DIABETES: PATHOPHYSIOLOGY
DIABETES MELLITUS: A VERY BASIC INTRODUCTION
GLYCOSYLATED HAEMOGLOBIN
MODY
DIABETES MELLITUS (TYPE 2): DIAGNOSIS
PREDIABETES AND IMPAIRED GLUCOSE REGULATION
DIABETES MELLITUS: MANAGEMENT OF TYPE 1
DIABETES MELLITUS: MANAGEMENT OF TYPE 2
T2DM MEDICATIONS
SULFONYLUREAS
THIAZOLIDINEDIONES
DIABETES MELLITUS: GLP-1 AND THE NEW DRUGS
SGLT-2 INHIBITORS
MEGLITINIDES
PREGNANCY: DIABETES MELLITUS
DIABETES MELLITUS: RAMADAN
DIABETIC KETOACIDOSIS
HYPEROSMOLAR HYPERGLYCAEMIC STATE
HYPOGLYCAEMIA
DIABETIC NEUROPATHY
DIABETIC FOOT DISEASE
DVLA: DIABETES MELLITUS
METABOLIC SYNDROME
REMNANT HYPERLIPIDAEMIA
OBESITY: THERAPEUTIC OPTIONS
THYROID DISORDERS: A VERY BASIC INTRODUCTION
THYROID FUNCTION TESTS
SICK EUTHYROID SYNDROME
SUBCLINICAL HYPOTHYROIDISM
HYPOTHYROIDISM: CAUSES
HYPOTHYROIDISM: FEATURES
HYPOTHYROIDISM: MANAGEMENT
HASHIMOTO’S THYROIDITIS
SUBACUTE (DE QUERVAIN’S) THYROIDITIS
RIEDEL’S THYROIDITIS
SUBCLINICAL HYPERTHYROIDISM
THYROTOXICOSIS: CAUSES AND INVESTIGATION
GRAVES’ DISEASE: FEATURES
GRAVES’ DISEASE: MANAGEMENT
THYROID EYE DISEASE
CARBIMAZOLE
TOXIC MULTINODULAR GOITRE
PREGNANCY: THYROID PROBLEMS
SKIN DISORDERS ASSOCIATED WITH THYROID DISEASE
THYROID STORM
THYROID CANCER
HYPOPARATHYROIDISM
PSEUDOHYPOPARATHYROIDISM
PRIMARY HYPERPARATHYROIDISM
CUSHING’S SYNDROME: CAUSES
CUSHING’S SYNDROME: INVESTIGATIONS
ADDISON’S DISEASE
ADDISON’S DISEASE: INVESTIGATIONS
ADDISONIAN CRISIS
AUTOIMMUNE POLYENDOCRINOPATHY SYNDROME
PRIMARY HYPERALDOSTERONISM
PHAEOCHROMOCYTOMA
ACROMEGALY: FEATURES
ACROMEGALY: INVESTIGATIONS
ACROMEGALY: MANAGEMENT
PROLACTIN AND GALACTORRHOEA
GYNAECOMASTIA
MULTIPLE ENDOCRINE NEOPLASIA
PITUITARY ADENOMA
DISORDERS OF SEX DEVELOPMENT
ANDROGEN INSENSITIVITY SYNDROME
CONGENITAL ADRENAL HYPERPLASIA
KALLMANN’S SYNDROME
KLINEFELTER’S SYNDROME
POLYCYSTIC OVARIAN SYNDROME: FEATURES AND INVESTIGATION
POLYCYSTIC OVARIAN SYNDROME: MANAGEMENT
MENSTRUAL CYCLE
AMENORRHOEA
PREMATURE OVARIAN FAILURE
HORMONE REPLACEMENT THERAPY: ADVERSE EFFECTS
CERVICAL CANCER
ENDOMETRIAL CANCER
OVARIAN CANCER
BARTTER’S SYNDROME
GITELMAN’S SYNDROME
LIDDLE’S SYNDROME
PENDRED’S SYNDROME
INSULINOMA
NEUROBLASTOMA
CORTICOSTEROIDS AND THEIR SIDE EFFECTS
DYNAMIC PITUITARY FUNCTION TESTS
WATER DEPRIVATION TEST
INSULIN STRESS TEST
HYPERCALCAEMIA: CAUSES
URINARY INCONTINENCE
PELVIC INFLAMMATORY DISEASE

Men 2 administrator 1 Views • 2 years ago

#MRCP PART ONE#PASSMEDICINE 2021 Endocrine 13 administrator 1 Views • 2 years ago

Ins and Outs of NETs – Know Your Genetics administrator 2 Views • 2 years ago

Understanding inherited risk factors for neuroendocrine tumors by Lauren Fishbein, MD, PhD, University of Chicago.
00:50 What is precision medicine?
04:30 Understanding DNA.
08:55 Inherited risk factors for NETs
11:15 MEN1
12:42 von Hippel Lindau disease (VHL1)
16:48 Who should have genetic testing
19:39 Gene mutations in NETs
21:47 Future of NET precision treatment
23:21 Summary
14:00 Neurofibromatosis Type 1 (NF1)
14:42 Para/Pheo

Multiple endocrine neoplasia (MEN) type 4 administrator 1 Views • 2 years ago

Multiple endocrine neoplasia type 4 is a novel syndrome increasingly being recognized in medical fields. Watch this video to know more about it.

Men 2 administrator 1 Views • 2 years ago

Gay
#gmod #garrysmod #gmodanimation #garrysmodanimation #tf2 #teamfortress2 #tf2animation

#MRCP - PART ONE #Endocrinology 2 administrator 5 Views • 2 years ago

Multiple Endocrine Neoplasia Seminar at Mayo Clinic: Thyroid and Parathyroid Disorders administrator 2 Views • 2 years ago

men2 2 administrator 3 Views • 2 years ago

Showing 3 out of 4

Please note that if you are under 18, you won't be able to access this site.

Multiple Endocrine Neoplasia Type 2

Language